Key result
Cardiac radiation therapy has emerged as a non-invasive treatment option for the management of refractory ventricular tachycardia, informing future basic and translational research.
Why the study?
Cardiac radiation therapy has emerged as a non-invasive option for refractory ventricular tachycardia, prompting a review of existing clinical and preclinical cardiac radiobiology literature.
Cardiac radiation therapy is an emerging non-invasive treatment option for the management of refractory ventricular tachycardia.
Radiation therapy is a well-established approach for safely and non-invasively treating solid tumours and benign diseases with high precision and accuracy. Cardiac radiation therapy has recently emerged as a non-invasive treatment option for the management of refractory ventricular tachycardia. Here we summarise existing clinical and preclinical literature surrounding cardiac radiobiology and discuss how these studies may inform basic and translational research, as well as clinical treatment paradigms in the management of arrhythmias.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) conducted a review in Refractory ventricular tachycardia. Cardiac radiation therapy was evaluated. Cardiac radiation therapy has emerged as a non-invasive treatment option for the management of refractory ventricular tachycardia, informing future basic and translational research.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: